Search research articles
Contact Us
Filters
Showing results (161-170 of 270) with videos related to
Page
of 27
Sort By:
British Journal of Haematology
|
July 29, 2024
Long-term complete remissions of refractory severe idiopathic immune thrombocytopenia treated with daratumumab: A case series
T Strüßmann, J Heinz, R Wäsch, et al.
Leukemia
|
August 3, 2005
Human hematopoietic cell transplantation results in generation of donor-derived epithelial cells
Y Metaxas, R Zeiser, A Schmitt-Graeff, et al.
Bone Marrow Transplantation
|
March 27, 2007
Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients
C Heining, A Spyridonidis, E Bernhardt, et al.
Bone Marrow Transplantation
|
January 1, 1993
Allogeneic family-unrelated bone marrow transplantation in acute and chronic myeloid leukemia
A A Fauser, G Köchling, W Digel, et al.
Journal of Cancer Research and Clinical Oncology
|
May 18, 2001
Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma
T Olencki, D Peereboom, L Wood, et al.
Veterinary Pathology
|
May 11, 2007
Epizootic of tularemia in an outdoor housed group of cynomolgus monkeys (Macaca fascicularis)
K Mätz-Rensing, A Floto, A Schrod, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 10, 2011
Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly
K Fritsch, B Kasenda, C Hader, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1992
Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancy
G T Budd, S Murthy, J Finke, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 23, 2000
Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: clinical and biologic effects
T Olencki, J Finke, R Tubbs, et al.
FEMS Immunology and Medical Microbiology
|
February 15, 2001
Study on the pathophysiology of experimental Burkholderia pseudomallei infection in mice
Y P Gauthier, R M Hagen, G S Brochier, et al.
Page
of 27
Search research articles
Search
Showing results (161-170 of 270) with videos related to
Sort By:
Page
of 27
British Journal of Haematology
|
July 29, 2024
Long-term complete remissions of refractory severe idiopathic immune thrombocytopenia treated with daratumumab: A case series
T Strüßmann, J Heinz, R Wäsch, et al.
Leukemia
|
August 3, 2005
Human hematopoietic cell transplantation results in generation of donor-derived epithelial cells
Y Metaxas, R Zeiser, A Schmitt-Graeff, et al.
Bone Marrow Transplantation
|
March 27, 2007
Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients
C Heining, A Spyridonidis, E Bernhardt, et al.
Bone Marrow Transplantation
|
January 1, 1993
Allogeneic family-unrelated bone marrow transplantation in acute and chronic myeloid leukemia
A A Fauser, G Köchling, W Digel, et al.
Journal of Cancer Research and Clinical Oncology
|
May 18, 2001
Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma
T Olencki, D Peereboom, L Wood, et al.
Veterinary Pathology
|
May 11, 2007
Epizootic of tularemia in an outdoor housed group of cynomolgus monkeys (Macaca fascicularis)
K Mätz-Rensing, A Floto, A Schrod, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 10, 2011
Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly
K Fritsch, B Kasenda, C Hader, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1992
Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancy
G T Budd, S Murthy, J Finke, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 23, 2000
Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: clinical and biologic effects
T Olencki, J Finke, R Tubbs, et al.
FEMS Immunology and Medical Microbiology
|
February 15, 2001
Study on the pathophysiology of experimental Burkholderia pseudomallei infection in mice
Y P Gauthier, R M Hagen, G S Brochier, et al.
Page
of 27